These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9930746)

  • 1. Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study.
    Rothblat DS; Schneider JS
    J Neurochem; 1999 Feb; 72(2):724-33. PubMed ID: 9930746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in release and clearance of extracellular dopamine in the striatum after spontaneous or GM1-ganglioside-stimulated recovery from experimental Parkinsonism.
    Schneider JS; Rothblat DS
    Restor Neurol Neurosci; 2000; 16(2):97-104. PubMed ID: 12671212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA; Rothblat DS; Joyce JN; Schneider JS
    Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats.
    Schneider JS; Rothblat DS
    Neuroscience; 1991; 44(2):421-9. PubMed ID: 1944893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous functional recovery from parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons.
    Rothblat DS; Schneider JS
    Brain Res Bull; 1994; 34(3):309-12. PubMed ID: 7914468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism.
    Schneider JS; Rothblat DS; DiStefano L
    Brain Res; 1994 Apr; 643(1-2):86-91. PubMed ID: 8032935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.
    Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH
    Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats.
    Rothblat DS; Schneider JS
    Brain Res; 1995 Dec; 705(1-2):1-14. PubMed ID: 8821727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
    Bezard E; Dovero S; Prunier C; Ravenscroft P; Chalon S; Guilloteau D; Crossman AR; Bioulac B; Brotchie JM; Gross CE
    J Neurosci; 2001 Sep; 21(17):6853-61. PubMed ID: 11517273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
    Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
    Elsworth JD; Brittan MS; Taylor JR; Sladek JR; Redmond DE; Innis RB; Zea-Ponce Y; Roth RH
    Brain Res; 1998 Jun; 795(1-2):55-62. PubMed ID: 9622593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F; Leng A; Mura A; Bettinetti L; Feldon J; Gmeiner P; Ferger B
    Biochem Pharmacol; 2003 Sep; 66(6):1025-32. PubMed ID: 12963489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter loss and clinical changes in MPTP-lesioned primates.
    Eberling JL; Bankiewicz KS; Pivirotto P; Bringas J; Chen K; Nowotnik DP; Steiner JP; Budinger TF; Jagust WJ
    Brain Res; 1999 Jun; 832(1-2):184-7. PubMed ID: 10375668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal enkephalin gene expression does not reflect parkinsonian signs.
    Schroeder JA; Schneider JS
    Neuroreport; 2000 Jun; 11(9):1799-802. PubMed ID: 10884022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
    Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
    J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.